Welcome to CSNpharm! For Research Use Only!
Home
+1-708-781-1677
sales@csnpharm.com
IRAK
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN18657 | PF-06650833 | 1817626-54-2 | PF-06650833 is an inhibitor ofInterleukin-1 receptor associated kinase 4 (IRAK4), and used to treat diseases such as rheumatoid arthritis, lupus, and lymphomas. |
| CSN18307 | IRAK-1-4 Inhibitor I | 509093-47-4 | IRAK-1-4 Inhibitor I is a IRAK-4 inhibitor with IC50 of 200 nM. |
| CSN17419 | IRAK Inhibitor 6 | 1042672-97-8 | IRAK Inhibitor 6 is an improved IRAK-4 inhibitor with IC50 value of 160 nM. |
| CSN19007 | IRAK Inhibitor 4 trans | 2070014-89-8 | IRAK inhibitor 4 trans is the trans form of IRAK inhibitor 4,which is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor. |
| CSN17391 | IRAK Inhibitor 4 | 1012104-68-5 | IRAK inhibitor 4 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor. |
| CSN17392 | IRAK Inhibitor 3 | 1012343-93-9 | IRAK inhibitor 3 is an interleukin-1 receptor associated kinase inhibitor. |
| CSN18593 | IRAK Inhibitor 2 | 928333-30-6 | IRAK inhibitor 2 is interleukin-1 receptor associated kinase inhibitor . |
| CSN17418 | IRAK Inhibitor 1 | 1042224-63-4 | IRAK inhibitor 1 is an interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor. |
| CSN21077 | CA-4948 | 1801343-74-7 | CA-4948 is a selective and potent IRAK4 inhibitor which can be used as a therapeutic agent for hematological cancers with dysregulated TLRMYD88IRAK4 signaling CA-4948 exhibits favorable DMPK properties oral bioavailability and is well tolerated in mice Furthermore CA-4948 is previously shown to exhibit dose-dependent efficacy in ABC-DLBCL MYD88-L265P xenograft tumor models |
| CSN14493 | Euscaphic Acid | 53155-25-2 | |
| CSN22689 | AS 2444697 | 1287665-60-4 |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
